FR940825-2-00075 FR940825-2-00049 Application Submission and Deadlines A. Preapplication Letter of Intent In order to schedule and conduct site visits as part of the formal review process, potential applicants are encouraged to submit a nonbinding letter of intent to apply to the Grants Management Officer (whose address is given in this section, Item B). It should be postmarked no later than one month prior to the submission deadline (September 24, 1994, for October 24, 1994, submission deadline). The letter should identify the relevant announcement number for the response, indicate the submission deadline which will be met, name the principal investigator, and specify the injury control theme or emphasis of the proposed center (e.g., acute care, biomechanics, epidemiology, prevention, intentional injury, or rehabilitation). The letter of intent does not influence review or funding decisions, but it will enable CDC to plan the review more efficiently. B. Applications Applicants should use Form PHS&hyph;398 (Rev. 9/91) and adhere to the ERRATA Instruction Sheet for PHS&hyph;398 contained in the Grant Application Kit. The narrative section for each project within an ICRC should not exceed 25 typewritten pages. Refer to section 4, page 10, of PHS&hyph;398 instructions for font type and size. Applications not adhering to these specifications may be returned to applicant. Applicants should submit an original and five copies to Henry S. Cassell, III, Grants Management Officer, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE., Room 300, Mailstop E&hyph;13, Atlanta, Georgia 30305. C. Deadlines Applications shall be considered as meeting the deadline above if they are either: 1. Received on or before the deadline date; or 2. Sent on or before the deadline date and received in time for submission to the peer review committee. Applicants should request a legibly dated U.S. Postal Service postmark or obtain a legibly dated receipt from a commercial carrier or the U.S. Postal Service. Private metered postmarks shall not be acceptable as proof of timely mailing. Applications which do not meet the criteria in C.1. or C.2. above are considered late applications and will be returned to the applicant. Supplemental materials received later than thirty days after the application receipt date are considered late and will be returned to the applicant. D. Receipt and Review Schedule This is a continuous announcement. Consequently, these receipt dates will be ongoing until further notice. The proposed timetables for receiving applications and awarding grants are as follows: ␣ 1Receipt of new/revised/supplementary/competitive renewal applications 1Initial review 1Secondary review 1Earliest award date October 24, 1994 January March September 1, 1995. Future receipt dates are as follows: ␣ 1Receipt of new/revised/supplementary/competitive renewal applications 1Initial review 1Secondary review 1Earliest award date October January March September. Where to Obtain Additional Information To receive additional written information call (404) 332&hyph;4561. You will be asked to leave your name, address, and phone number and will need to refer to Announcement Number 405. You will receive a complete program description, information on application procedures, and application forms. If you have questions after reviewing the contents of all the documents, business management technical assistance may be obtained from Maggie Slay, Grants Management Specialist, Centers For Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE., MS&hyph;E13, Atlanta, Georgia 30305, telephone (404) 842&hyph;6797. Programmatic technical assistance may be obtained from Tom Voglesonger, Program Manager, Injury Control Research Centers, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway, MS&hyph;K58, Atlanta, Georgia 30341&hyph;3724, telephone (404) 488&hyph;4265. Potential applicants may obtain a copy of ``Healthy People 2000'' (Full Report; Stock No. 017&hyph;001&hyph;00474&hyph;0) or ``Healthy People 2000'' (Summary Report; Stock No. 017&hyph;001&hyph;00473&hyph;1) through the Superintendent of Documents, Government Printing Office, Washington, DC 20402&hyph;9325, telephone (202) 783&hyph;3238. Dated: August 17, 1994. Joseph R. Carter, Acting Associate Director for Management and Operations, Centers for Disease Control and Prevention (CDC). [FR Doc. 94&hyph;20909 Filed 8&hyph;24&hyph;94; 8:45 am] BILLING CODE 4163&hyph;18&hyph;P
